MAINZ-SLEEPREG: Mainz Register of Patients With Sleep Disorders

Sponsor
Johannes Gutenberg University Mainz (Other)
Overall Status
Recruiting
CT.gov ID
NCT05321355
Collaborator
(none)
500
1
96
5.2

Study Details

Study Description

Brief Summary

Prospective longitudinal observational registry study of all patients with sleep disorders treated in the Mainz Comprehensive Epilepsy and Sleep Medicine Center with the focus on the course of the disease and quality of life.

Condition or Disease Intervention/Treatment Phase
  • Other: no interventions, only observation

Detailed Description

Clinical parameters of patients, such as onset of the disease, prior medication, disease severity, which are important for the data analysis also collected retrospectively before the initiation of the registry. Data on the quality of life is collected only prospectively

Study Design

Study Type:
Observational [Patient Registry]
Anticipated Enrollment :
500 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Study on Disease Course and Quality of Life in Patients With Sleep Disorders (Mainz Sleep Registry)
Actual Study Start Date :
Feb 1, 2022
Anticipated Primary Completion Date :
Jan 31, 2030
Anticipated Study Completion Date :
Jan 31, 2030

Outcome Measures

Primary Outcome Measures

  1. Excessive daytime sleepiness (EDS) as measure by Epworth Sleepiness Scale (ESS) after 3 months [3 months]

    EDS measure by ESS at the follow-up after 3 months

  2. European Quality of Life 5 dimensions Index (EQ 5D Index) [3 months]

    health-related quality of life measured by EQ5D-Index (European Quality of Life 5 dimensions), rating from 0 (worst possible state) to 1 (best possible state)

  3. Excessive daytime sleepiness (EDS) as measure by Epworth Sleepiness Scale (ESS) after 6 months [6 months]

    EDS measure by ESS at the follow-up after 6 months

  4. European Quality of Life 5 dimensions Index (EQ 5D Index) [6 months]

    health-related quality of life measured by EQ5D-Index (European Quality of Life 5 dimensions), rating from 0 (worst possible state) to 1 (best possible state)

Secondary Outcome Measures

  1. Multidimensional Fatigue Inventory [3 months]

    Multidimensional Fatigue Inventory: 20-item self-report instrument designed to measure fatigue. Measures range from 0-100, representing more severe fatigue at higher scores

  2. Multidimensional Fatigue Inventory [6 months]

    Multidimensional Fatigue Inventory: 20-item self-report instrument designed to measure fatigue. Measures range from 0-100, representing more severe fatigue at higher scores

  3. Beck Depression Inventory II [6 months]

    Beck Depression Inventory II: higher scores correspond to more severe depression (range 0-63)

  4. Beck Depression Inventory II [12 months]

    Beck Depression Inventory II: higher scores correspond to more severe depression (range

  5. Resilience Scale 13 [6 months]

    Resilience Scale 13 (short version with 13 questions): 13-66 points correspond with low resilience, 67-72 with moderate and 73-91 with high resilience

  6. Resilience Scale 13 [12 months]

    Resilience Scale 13 (short version with 13 questions): 13-66 points correspond with low

  7. European Quality of Life visual analogue scale (EQ-VAS) [6 months]

    European Quality of Life visual analogue scale (EQ-VAS) (ranges from 0 to 100, where 0 is the worst anf 100 the best state)

  8. European Quality of Life visual analogue scale (EQ-VAS) [12 months]

    European Quality of Life visual analogue scale (EQ-VAS) (ranges from 0 to 100, where 0 is the worst anf 100 the best state)

  9. Ullanlinna Narcolepsy Scale (UNS) [3 months]

    scale to identify the burden of narcolepsy

  10. Ullanlinna Narcolepsy Scale (UNS) [6 months]

    scale to identify the burden of narcolepsy

  11. World Health Organization Quality of Life-BREF (WHOQOL-BREF) [6 months]

    World Health Organization Quality of Life-BREF (WHOQOL-BREF), a scale to assess overall quality of life with a range 0-100 (higher scores correspond better quality of life)

  12. World Health Organization Quality of Life-BREF (WHOQOL-BREF) [12 months]

    World Health Organization Quality of Life-BREF (WHOQOL-BREF), a scale to assess overall quality of life with a range 0-100 (higher scores correspond better quality of life)

  13. Pittsburgh Sleep Quality Index [6 months]

    Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances, scoring between 0 and 21 with higher scores corresponding to worse sleep quality

  14. Pittsburgh Sleep Quality Index [12 months]

    Pittsburgh Sleep Quality Index (PSQI) is a self-rated questionnaire which assesses sleep quality and disturbances, scoring between 0 and 21 with higher scores corresponding to worse sleep quality

  15. Berlin Social Support Scales (BSSS) [6 months]

    Berlin Social Support Scales (BSSS) is used to assess the amount of emotional, informational and instrumental support received by patients: Total scores ranged from 15 to 60, higher scores identify better support

  16. Berlin Social Support Scales (BSSS) [12 months]

    Berlin Social Support Scales (BSSS) is used to assess the amount of emotional, informational and instrumental support received by patients: Total scores ranged from 15 to 60, higher scores identify better support

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 120 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:

patients with neurological sleep disorders

Exclusion Criteria:

patients aged <18 years patients who cannot provide informed consent and don't have a legal guardian

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mainz Comprehensive Epilepsy and Sleep Medicine Center Mainz Rheinland-Pfalz Germany 55131

Sponsors and Collaborators

  • Johannes Gutenberg University Mainz

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dr. Yaroslav Winter, Head of Mainz Comprehensive Epilepsy and Sleep Medicine Center, Johannes Gutenberg University Mainz
ClinicalTrials.gov Identifier:
NCT05321355
Other Study ID Numbers:
  • MAINZ-SLEEPREG
First Posted:
Apr 11, 2022
Last Update Posted:
Apr 11, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 11, 2022